Blood purification therapies in methotrexate-induced acute kidney injury: four case reports

Blood purification therapies in methotrexate-induced acute kidney injury: four case reports

Abstract Background Methotrexate (MTX), a folic acid antimetabolite, is administered at a high dose for the treatment of diseases such as leukemia and malignant lymphoma. Often, an effort is made to reduce the adverse effects of MTX by monitoring MTX concentration in the blood and administering a hi...

Full description

Bibliographic Details
Main Authors: Emi Fujikura, Maho Akiu, Kenichiro Miyauchi, Mai Yoshida, Satoshi Aoki, Tae Yamamoto, Kaori Narumi, Noriko Yanagisawa, Takashi Nakamichi, Mariko Miyazaki, Hiroshi Sato, Sadayoshi Ito
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Renal Replacement Therapy
Subjects:
High-dose methotrexate
Acute kidney injury
Blood purification therapy
Reduction rates
Online Access:http://link.springer.com/article/10.1186/s41100-017-0129-4

Internet

http://link.springer.com/article/10.1186/s41100-017-0129-4

Similar Items